Navigation path

Cancer-Killing Stem Cells Could Be Used To Treat Cancer

Researchers in Japan have for the first time shown it is possible to make cancer-specific immune system cells from induced pluripotent stem cells (iPSCs). Their work brings closer the day when therapies use cloned versions of patients' own cells to boost their immune system's natural ability to kill cancer cells.


Nanodiamonds: A cancer patient's best friend?


Nanometric scale diamond particles could offer a new way to detect cancer far earlier than previously thought.


The trouble is that previous solutions did not allow monitoring processes within living cells for any extended period of time. "Our key challenge was to replace fluorescent bimolecular dyes that are currently used as luminescence markers in cancer cell research," explains Nesladek.


The landscape of medical oncology in Europe threatened


Many large European countries may be facing a future shortage of medical oncologists without realizing it - a situation that could have dire consequences for cancer patients.


The number of people who develop cancers in greater Europe is expected to grow to 3.4 million each year by 2020, a 20% increase from 2002. It is vital that countries increase their numbers of cancer specialists to match that growth, ESMO warns.


Chronic disease and sitting time in middle-aged Australian males: findings from the 45 and Up Study


Compared to females, males experience a range of health inequities including higher rates of diabetes and cardiovascular disease. Although sitting time is emerging as a distinct risk factor for chronic disease, research on the association of sitting time and chronic disease in middle-aged Australian males is limited.

The link between air pollution and cancer

There have been several stories in the media today about air pollution causing cancer.

Advances in Addressing Cancers

First-ever estimates recently revealed that cancer costs the EU €126 billion a year, consisting of lost productivity and cost of care and treatments.  The more an EU nation spends on health, the fewer deaths after cancer diagnosis in that country.  Eastern Europe had lower cancer incidence and higher cancer mortality, and the opposite was true in Western Europe, suggesting that expenditures will determine mortality rates.



Personalized Medicine and Cancer

Cancer is one of the leading causes of death in the United States, and more than 1.5 million new cases and more than 0.5 million deaths were reported during 2010 in the United States alone. Following completion of the sequencing of the human genome, substantial progress has been made in characterizing the human epigenome, proteome, and metabolome; a better understanding of pharmacogenomics has been developed, and the potential for customizing health care for the individual has grown tremendously.

Print It: 3-D Bio-Printing Makes Better Regenerative Implants

Desktop 3-D printers can already pump out a toy trinket, gear set or even parts to make another printer. Medical researchers are also taking advantage of this accelerating technology to expand their options for regenerative medicine.


Subscribe to RSS - cancer